90310 WellnessCast with Dr Clare

GLP-1s for Everyone | 90310 WellnessCast with Dr. Clare
Ozempic, Wegovy, Mounjaro — you've heard the names. The pure products vs. the mixed ones, vs the black market... where do you even start as a patient?
Dr. Clare breaks down the real picture on GLP-1 receptor agonists: the genuine upsides, the genuine downsides, and two safety stories that are NOT equally true. One falls apart under scrutiny. The other deserves your attention. Let's sort out which is which. 
In this episode:
→ What GLP-1 drugs actually are and how they work
→ "Food noise" — the cognitive effect researchers are now taking seriously
→ The lizard venom myth, debunked
→ Vision loss scare vs gastroparesis risk — which one is real
→ Muscle loss: the underdiscussed side effect and what to do about it
→ SA registration status — what's legal for weight management vs diabetes
→ The iDexis court ruling and what it means for compounded alternatives
→ Where the money goes: Aspen, Eli Lilly, and the SA commercial chain
→ Who this is actually a good fit for
All sources and evidence grades are publicly available at: https://90310-wellness-cast.base44.app
→ Episode Information → GLP-1s for Everyone
Connect with us: Instagram: @90310wellness
Weight-loss programme waitlist: launching August 2026 — DM us or visit the website.
⚠️ This episode is for educational purposes only and does not constitute medical advice. Always consult a registered healthcare practitioner before starting or stopping any medication.

A full clinical update on GLP-1 receptor agonists for prescribers. Dr. Clare covers the complete arc from the discovery of the incretin effect through to tirzepatide's dual GLP-1/GIP mechanism, the South African regulatory landscape as of July 2026, pharmacovigilance data on compounded and black-market products, the emerging evidence on weight-independent anti-inflammatory effects, and a practical framework for patient facing conversations.
This episode exists because GLP-1s are one of the fastest-moving areas in medicine, and the noise — from industry, from media, and from social platforms — is complicating what should be a straightforward clinical conversation. The goal is one honest, well-evidenced reference you can come back to.
WHAT'S COVERED
- Drug family history: from Gila monster venom (exenatide) to semaglutide to tirzepatide
- GLP-1 vs GIP dual agonism — what makes tirzepatide mechanistically different
- How the drug works: the full cascade from injection site to hypothalamus, pancreas, gut, heart, and kidney
- SA registration status for Victoza, Saxenda, Ozempic, Wegovy, and Mounjaro as of 2026
- The compounding and black-market safety story: FAERS data, UK counterfeit deaths, SA non-medical provider landscape
- The iDexis Class I recall and the [2026] ZAGPPHC 612 ruling — prescriber liability in plain terms
- Anti-inflammatory effects of GLP-1 agonists independent of weight loss: cardiovascular, MASH, renal, and neurological evidence
- NAION and ocular safety — why the scary headlines didn't hold up under scrutiny
- GI motility risk — why this signal is real and how to counsel patients
- Lean mass loss — the numbers, and why protein and resistance training are clinical advice, not optional extras
- Regain after stopping — the long-term commitment conversation
EVIDENCE TREE AND FULL SOURCE LIST
Full evidence-graded source list (1–6 ladder, open-access links, COI disclosures, retraction status):
https://docs.google.com/document/d/1GBuW1ZpqSrKichqhlgnVAaQsJdJZqoxlDjU9MRIuY9w/edit
SA registration and SAHPRA product register: https://www.sahpra.org.za/medicines-control/databases/
CONNECT WITH 90310 WELLNESSCAST
 
Instagram: https://www.instagram.com/90310wellness
Website and episode archive: https://90310wellnesscast.base44.app
Find Dr Clare on her other platform too: Birth Stories Mzansi app: https://birthstoriesmzansi.base44.app
 
Got a question, a topic you'd like covered, or a clinical disagreement with something in this episode? Reach out — the show is better for it.
Email: drclare@beauty-doctor.org
COMPANION EPISODE
A lay-audience version of this episode — GLP-1s for Everyone — covers the same ground in patient-accessible language. If you, like many of us, get tired of re-explaining the same GLP-1 questions in every consultation: share it, save it, send it ahead of appointments. Available on all major platforms, coming soon!!
DISCLAIMER
This episode is for educational purposes and is aimed at qualified healthcare professionals. It does not constitute prescribing advice and does not replace clinical judgement or current local guidelines. Always refer to current SAHPRA-registered product information and consult relevant clinical guidelines for your patient population.
SA regulatory citations: Medicines and Related Substances Act 101 of 1965; SAPC/SAHPRA joint statement on compounding; [2026] ZAGPPHC 612 (Novo Nordisk SA (Pty) Ltd v iDexis (Pty) Ltd).

90310 WellnessCast with Dr. Clare — Approaches to Medicine🧭
Why do two people with the exact same symptom end up in completely different places — one at the GP, one at an acupuncturist? It's not that one's right and one's wrong. We break down the real models of medicine (biomedical, biopsychosocial, functional, traditional Eastern) and the behavioural science behind why we choose the care we choose — setting the stage for next episode's conversation with the founder of 90310 himself.
📖 Full evidence-graded source list: https://ben-99b6679a.base44.app/functions/episodeNotes?episode=approaches-to-medicine
💬 Want a team that looks at the whole picture? Book a chat with the 90310 team: https://ben-99b6679a.base44.app/functions/intakeForm?episode=approaches-to-medicine
Follow along: @90310wellness | @beautydoctor.cc

90310 WellnessCast with Dr. Clare — Episode 1 Intermittent Fasting: Does It Really Live Up to the Hype? 🍽️
The diet everyone swears by just got put through a rigorous trial — and the results aren't quite what wellness culture wants to hear. We dig into the real evidence (including the studies that complicate the popular story), what's actually proven vs. still theory, and why this debate is heating up again thanks to GLP-1 drugs.
📖 Full evidence-graded source list: https://ben-99b6679a.base44.app/functions/episodeNotes?episode=intermittent-fasting-does-it-really-live-up-to-the-hype
💬 Thinking about your options? Book a chat with the 90310 team: https://ben-99b6679a.base44.app/functions/intakeForm?episode=intermittent-fasting
Follow along: @90310wellness | @beautydoctor.cc
Got a topic you want covered or questions on this episode? Send them our way — future episodes are shaped by what you want to know.